{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T02:52:50Z","timestamp":1787539970861,"version":"build-2736575974"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"8","license":[{"start":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T00:00:00Z","timestamp":1503619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Veterans Health Administration Merit Review Program","award":["1 I01 BX003644-01"],"award-info":[{"award-number":["1 I01 BX003644-01"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0183469","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T17:35:08Z","timestamp":1503682508000},"page":"e0183469","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["A Trp53fl\/flPtenfl\/fl mouse model of undifferentiated pleomorphic sarcoma mediated by adeno-Cre injection and in vivo bioluminescence imaging"],"prefix":"10.1371","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8261-1566","authenticated-orcid":true,"given":"Marisa R.","family":"Buchakjian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M.","family":"Merritt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devon L.","family":"Moose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam J.","family":"Dupuy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munir R.","family":"Tanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2017,8,25]]},"reference":[{"key":"ref1","unstructured":"National Cancer Institute [Internet]. Updated 2014 Nov 5; cited 2016 Nov 9. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.cancer.gov\/research\/progress\/snapshots\/sarcoma\" xlink:type=\"simple\">www.cancer.gov\/research\/progress\/snapshots\/sarcoma<\/ext-link>."},{"issue":"9","key":"ref2","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/nrc3087","article-title":"Advances in sarcoma genomics and new therapeutic targets","volume":"11","author":"BS Taylor","year":"2011","journal-title":"Nat Rev Cancer"},{"issue":"8","key":"ref3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1586\/era.09.76","article-title":"MFH classification: differentiating undifferentiated pleomorphic sarcoma in the 21<sup>st<\/sup> Century","volume":"9","author":"I Matushansky","year":"2009","journal-title":"Expert Rev Anticancer Ther"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1053\/j.seminoncol.2009.06.007","article-title":"Sarcomas with spindle cell morphology","volume":"36","author":"P Collini","year":"2009","journal-title":"Semin Oncol"},{"issue":"6","key":"ref5","first-page":"1941","article-title":"Soft tissue sarcomas of adults: state of the translational science","volume":"9","author":"EC Borden","year":"2003","journal-title":"Clin Cancer Res"},{"issue":"30)","key":"ref6","first-page":"180","article-title":"New therapeutic targets in soft tissue sarcoma","volume":"19","author":"EG Demicco","year":"2012","journal-title":"Adv Anat Pathol"},{"issue":"3","key":"ref7","first-page":"416","article-title":"Comprehensive mapping of p53 pathway alterations reveals an apparent role for both SNP309 and MDM2 amplification in sarcomagenesis","volume":"17","author":"M Ito","year":"2011","journal-title":"Cancer Res"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrc3711","article-title":"Unravelling mechanisms of p53-mediated tumour suppression","volume":"14","author":"KT Bieging","year":"2014","journal-title":"Nat Rav Cancer"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s40291-013-0020-0","article-title":"TP53 testing and Li-Fraumeni syndrome: current status of clinical applications and future directions","volume":"17","author":"AD Sorrell","year":"2013","journal-title":"Mol Diagn Ther"},{"issue":"5","key":"ref10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/nrm3330","article-title":"The functions and regulation of the PTEN tumour suppressor","volume":"13","author":"MS Song","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"4","key":"ref11","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.humpath.2005.01.017","article-title":"Genetic and epigenetic alterations of the PTEN gene in soft tissue sarcomas","volume":"36","author":"K Kawaguchi","year":"2005","journal-title":"Hum Pathol"},{"issue":"21","key":"ref12","doi-asserted-by":"crossref","first-page":"5940","DOI":"10.1158\/1078-0432.CCR-13-0850","article-title":"Dual blockade of the PI3K\/AKT\/mTOR (AZD8055) and RAS\/MEK\/ERK (AZD6244) pathways synergistically inhibits rhabdomyosarcoma cell growth in vitro and in vivo","volume":"19","author":"J Renshaw","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"6","key":"ref13","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1016\/j.ajpath.2013.02.035","article-title":"Dual Pten\/Tp53 suppression promotes sarcoma progression by activating Notch Signaling","volume":"182","author":"MV Guijarro","year":"2013","journal-title":"Am J Pathol"},{"issue":"4","key":"ref14","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1162\/153535003322750637","article-title":"Mouse reporter strain for noninvasive bioluminescent imaging of cells that have undergone Cre-mediated recombination","volume":"2","author":"M Safran","year":"2003","journal-title":"Mol Imaging"},{"issue":"9\u201310","key":"ref15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1242\/dmm.005223","article-title":"Animal models of soft-tissue sarcoma","volume":"3","author":"RD Dodd","year":"2010","journal-title":"Dis Model Mech"},{"issue":"6366","key":"ref16","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/356215a0","article-title":"Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours","volume":"356","author":"LA Donehower","year":"1992","journal-title":"Nature"},{"issue":"11","key":"ref17","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1038\/cdd.2015.27","article-title":"Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcoma","volume":"22","author":"AM Puzio-Kuter","year":"2015","journal-title":"Cell Death Differ"},{"issue":"8","key":"ref18","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1038\/nm1602","article-title":"A spatially and temporally restricted mouse model of soft tissue sarcoma","volume":"13","author":"DG Kirsch","year":"2007","journal-title":"Nat Med"},{"issue":"11","key":"ref19","doi-asserted-by":"crossref","first-page":"e8075","DOI":"10.1371\/journal.pone.0008075","article-title":"Cross species genomic analysis identifies a mouse model as undifferentiated pleomorphic sarcoma\/malignant fibrous histiocytoma","volume":"4","author":"JK Mito","year":"2009","journal-title":"PLoS One"},{"issue":"4","key":"ref20","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1172\/JCI86573","article-title":"MicroRNA-182 drives metastasis of primary sarcomas by targeting multiple genes","volume":"126","author":"M Sachdeva","year":"2016","journal-title":"J Clin Invest"},{"issue":"7385","key":"ref21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nature10803","article-title":"Expression of tumour-specific antigens underlies cancer immunoediting","volume":"482","author":"M DuPage","year":"2012","journal-title":"Nature"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ajpath.2011.03.014","article-title":"Slow disease progression in a C57BL\/6 pten-deficient mouse model of prostate cancer","volume":"179","author":"RU Svensson","year":"2011","journal-title":"Am J Pathol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1126\/science.1065518","article-title":"Negative regulation of neural stem\/progenitor cell proliferation by the pten suppressor gene in vivo","volume":"294","author":"M Groszer","year":"2001","journal-title":"Science"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1101\/gad.14.8.994","article-title":"Induction of medulloblastomas in p54-null mutant mice by somatic inactivation of rb in the external granular layer cells of the cerebellum","volume":"14","author":"S Marino","year":"2000","journal-title":"Genes and Dev"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/S0959-8049(02)00410-0","article-title":"Advancing animal models of neoplasia through in vivo bioluminescence imaging","volume":"16","author":"M Edinger","year":"2002","journal-title":"Eur J Cancer"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1097\/01.LAB.0000036877.36379.1F","article-title":"Combined noninvasive imaging and luminometric quantification of luciferase-labeled human prostate tumors and metastases","volume":"11","author":"N El Hilali","year":"2002","journal-title":"Lab Invest"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1158\/0008-5472.CAN-10-2666","article-title":"Pharmacokinetic modeling of tumor bioluminescence implicates efflux, and not influx, as the bigger hurdle in cancer drug therapy","volume":"3","author":"H Sim","year":"2011","journal-title":"Cancer Res"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-4939-2297-0_13","article-title":"Methods to generate genetically engineered mouse models of soft tissue sarcomas","volume":"1267","author":"RD Dodd","year":"2015","journal-title":"Methods Mol Biol"},{"key":"ref29","first-page":"1","article-title":"PD-1 and PD-L1 antibodies in cancer: current status and future directions","volume":"1","author":"AV Balar","year":"2017","journal-title":"Cancer Immunol Immunother"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0183469","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T19:59:56Z","timestamp":1659383996000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0183469"}},"subtitle":[],"editor":[{"given":"David M","family":"Loeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,25]]},"references-count":29,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0183469","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,25]]}}}